7/10/24 16:15 | 7/8/24 | IRON | Disc Medicine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Quisel John D | MA | DO | CEO | M.d | 3 | 1.01 | 0 | 3 | 4 | 72 | D | | | | | | | | | | | | | | |
1/3/24 16:05 | 12/29/23 | IRON | Disc Medicine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Quisel John D | MA | DO | CEO | M.d | 3 | 1.01 | 0 | 3 | New | 3 | D | | | | | | | | | | | | | | |
1/3/20 21:45 | 1/2/20 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | EVP,Chie | S | -307 | 52.52 | 0 | -6 | -10 | 53 | D | | | | | | | | | | | | | | |
9/10/19 20:23 | 9/10/19 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | EVP,Chie | S | -162 | 45.23 | 0 | -4 | -6 | 59 | D | | | | | | | | | | | | | | |
7/11/19 16:26 | 7/9/19 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | EVP,Chie | M.d | 43 | 4.82 | 0 | 9 | 17 | 63 | D | | | | | | | | | | | | | | |
4/11/19 16:58 | 4/9/19 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | EVP,CBO, | S | -162 | 44.64 | 0 | -4 | -6 | 54 | D | | | | | | | | | | | | | | |
1/4/19 18:35 | 1/2/19 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | EVP,CBO, | S | -254 | 42.83 | 0 | -6 | -10 | 53 | D | | | | | | | | | | | | | | |
4/4/18 16:40 | 4/3/18 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP,Corp | S | -46 | 38.40 | 0 | -1 | -2 | 57 | D | | | | | | | | | | | | | | |
1/4/18 19:03 | 1/2/18 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP,Corp | S | -184 | 42.42 | 0 | -4 | -8 | 53 | D | | | | | | | | | | | | | | |
9/14/17 17:03 | 9/12/17 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP,Corp | S.m | -196 | 38.42 | 0 | -5 | -8 | 57 | D | | | | | | | | | | | | | | |
1/6/17 17:13 | 1/4/17 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP,Bus. | S | -47 | 27.36 | 12 | -2 | -3 | 55 | D | -29 | -27 | -20 | -25 | -27 | -6 | -1 | 6 | 1 | 0 | -8 | -1 | | |
9/23/16 17:09 | 9/21/16 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP,Bus. | M.d | 380 | 14.63 | 9 | 26 | 86 | 56 | D | 42 | 29 | 65 | 14 | 36 | 32 | 21 | 10 | -1 | -8 | -26 | -30 | -32 | |
9/23/16 17:09 | 9/21/16 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP,Bus. | S.d | -1,748 | 38.05 | 9 | -46 | -45 | 56 | D | 42 | 29 | 65 | 14 | 36 | 32 | 21 | 10 | -1 | -8 | -26 | -30 | -32 | |
9/13/16 16:23 | 9/12/16 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP,Bus. | M.d | 88 | 5.34 | 7 | 16 | 27 | 76 | D | 25 | -3 | 19 | -7 | -5 | 6 | 9 | 3 | 4 | 10 | 2 | -11 | -14 | |
9/13/16 16:23 | 9/12/16 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP,Bus. | S.d | -689 | 32.14 | 7 | -21 | -22 | 76 | D | 25 | -3 | 19 | -7 | -5 | 6 | 9 | 3 | 4 | 10 | 2 | -11 | -14 | |
9/16/15 17:01 | 9/14/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 21 | 3.88 | 6 | 6 | 8 | 76 | D | | 37 | -15 | 14 | 21 | 30 | 25 | 9 | 8 | 0 | -29 | 29 | -22 | 6 |
9/16/15 17:01 | 9/14/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | S.d | -183 | 33.35 | 6 | -6 | -7 | 76 | D | | 37 | -15 | 14 | 21 | 30 | 25 | 9 | 8 | 0 | -29 | 29 | -22 | 6 |
8/17/15 16:27 | 8/14/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 30 | 5.50 | 5 | 6 | 18 | 36 | D | | 4 | -18 | -2 | 3 | 10 | 8 | 10 | -5 | -13 | 9 | 10 | -17 | -7 |
8/17/15 16:27 | 8/14/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | S.d | -170 | 30.83 | 5 | -6 | -13 | 36 | D | | 4 | -18 | -2 | 3 | 10 | 8 | 10 | -5 | -13 | 9 | 10 | -17 | -7 |
8/3/15 20:18 | 7/30/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 71 | 5.28 | 4 | 13 | 59 | 36 | D | | -3 | -27 | 0 | -8 | -5 | -11 | -1 | 0 | -3 | 0 | 6 | 6 | 19 |
7/16/15 16:29 | 7/14/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 32 | 5.88 | 6 | 6 | 32 | 23 | D | | 18 | -20 | -5 | 0 | 1 | 6 | 8 | 1 | -1 | 0 | -32 | 3 | 1 |
7/16/15 16:29 | 7/14/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | S.d | -165 | 30.00 | 6 | -6 | -20 | 23 | D | | 18 | -20 | -5 | 0 | 1 | 6 | 8 | 1 | -1 | 0 | -32 | 3 | 1 |
6/18/15 18:14 | 6/17/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 30 | 3.88 | 5 | 8 | 51 | 23 | D | | -9 | -19 | -25 | 9 | -7 | -5 | -2 | -2 | 1 | 4 | 3 | 39 | 15 |
6/16/15 17:20 | 6/15/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 32 | 5.88 | 5 | 6 | 58 | 15 | D | | -8 | -25 | -24 | 6 | -7 | -2 | -1 | 1 | 4 | 5 | 11 | 36 | 16 |
6/16/15 17:20 | 6/15/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | S.d | -171 | 31.13 | 5 | -6 | -27 | 15 | D | | -8 | -25 | -24 | 6 | -7 | -2 | -1 | 1 | 4 | 5 | 11 | 36 | 16 |
5/18/15 16:20 | 5/14/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 32 | 5.88 | 7 | 6 | 58 | 15 | D | | 1 | -6 | -16 | -7 | 0 | 12 | -1 | 1 | 1 | -6 | -4 | 9 | -1 |
5/18/15 16:20 | 5/14/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | S.d | -174 | 31.59 | 7 | -6 | -27 | 15 | D | | 1 | -6 | -16 | -7 | 0 | 12 | -1 | 1 | 1 | -6 | -4 | 9 | -1 |
3/17/15 16:37 | 3/13/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.dm | 53 | 5.54 | 9 | 10 | 173 | 15 | D | | -9 | 59 | -1 | 6 | 4 | -1 | 0 | 0 | -1 | -19 | -26 | -18 | -39 |
3/17/15 16:37 | 3/13/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | S.dm | -390 | 41.00 | 9 | -10 | -39 | 15 | D | | -9 | 59 | -1 | 6 | 4 | -1 | 0 | 0 | -1 | -19 | -26 | -18 | -39 |
3/6/15 16:08 | 3/4/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 46 | 4.85 | 8 | 10 | 173 | 15 | D | | -21 | 61 | 16 | 7 | 9 | 5 | 4 | 1 | 4 | -15 | -21 | -27 | -29 |
3/6/15 16:08 | 3/4/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | S.d | -387 | 40.77 | 8 | -10 | -39 | 15 | D | | -21 | 61 | 16 | 7 | 9 | 5 | 4 | 1 | 4 | -15 | -21 | -27 | -29 |
1/16/15 16:25 | 1/14/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 34 | 3.61 | 12 | 10 | 173 | 15 | D | | -16 | 60 | 41 | 15 | 6 | 8 | 0 | 0 | -6 | -8 | -19 | -22 | -20 |
1/16/15 16:25 | 1/14/15 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | S.d | -380 | 40.05 | 12 | -10 | -39 | 15 | D | | -16 | 60 | 41 | 15 | 6 | 8 | 0 | 0 | -6 | -8 | -19 | -22 | -20 |
12/19/14 17:21 | 12/17/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 58 | 3.88 | 16 | 15 | New | 15 | D | | 49 | 16 | 67 | 19 | 4 | -7 | 7 | -1 | 4 | 0 | 5 | -17 | 13 |
12/16/14 17:27 | 12/12/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 4 | 0.9200 | 15 | 4 | | 0 | D | | 30 | 11 | 51 | 11 | 5 | 3 | -13 | 6 | 2 | 9 | 10 | -18 | 16 |
12/16/14 17:27 | 12/12/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | S.d | -165 | 41.35 | 15 | -4 | -100 | 0 | D | | 30 | 11 | 51 | 11 | 5 | 3 | -13 | 6 | 2 | 9 | 10 | -18 | 16 |
11/18/14 17:19 | 11/14/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 4 | 0.9200 | 8 | 4 | | 0 | D | | 68 | 5 | 16 | 13 | -7 | -3 | -2 | -3 | 9 | 19 | 22 | -1 | 7 |
11/18/14 17:19 | 11/14/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | S.d | -134 | 33.49 | 8 | -4 | -100 | 0 | D | | 68 | 5 | 16 | 13 | -7 | -3 | -2 | -3 | 9 | 19 | 22 | -1 | 7 |
11/14/14 16:04 | 11/12/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 32 | 6.35 | 8 | 5 | | 0 | D | | 81 | 10 | 18 | 14 | 3 | 2 | 9 | -1 | 2 | 13 | 14 | -2 | 6 |
11/14/14 16:04 | 11/12/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | S.d | -166 | 33.14 | 8 | -5 | -100 | 0 | D | | 81 | 10 | 18 | 14 | 3 | 2 | 9 | -1 | 2 | 13 | 14 | -2 | 6 |
10/16/14 16:14 | 10/14/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 4 | 0.9200 | 7 | 4 | | 0 | D | | 32 | -23 | 14 | 12 | 2 | -1 | -1 | 0 | 0 | 21 | 41 | 16 | -16 |
10/16/14 16:14 | 10/14/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | S.d | -116 | 29.02 | 7 | -4 | -100 | 0 | D | | 32 | -23 | 14 | 12 | 2 | -1 | -1 | 0 | 0 | 21 | 41 | 16 | -16 |
10/1/14 18:00 | 9/30/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 44 | 6.22 | 6 | 7 | | 0 | D | | 36 | -11 | -11 | 6 | 18 | 25 | 5 | 3 | -1 | 17 | 27 | 26 | -16 |
10/1/14 18:00 | 9/30/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | S.d | -210 | 30.01 | 6 | -7 | -100 | 0 | D | | 36 | -11 | -11 | 6 | 18 | 25 | 5 | 3 | -1 | 17 | 27 | 26 | -16 |
9/12/14 17:09 | 9/12/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 2 | 0.9200 | 4 | 2 | | 0 | D | | | -43 | -24 | -12 | 0 | -1 | 4 | -1 | -4 | 15 | 68 | 59 | 30 |
9/12/14 17:09 | 9/12/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | S.d | -51 | 25.43 | 4 | -2 | -100 | 0 | D | | | -43 | -24 | -12 | 0 | -1 | 4 | -1 | -4 | 15 | 68 | 59 | 30 |
8/15/14 16:12 | 8/14/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 60 | 4.61 | 5 | 13 | | 0 | D | | | -32 | -5 | -10 | 7 | 1 | 0 | -1 | -12 | -14 | 13 | 27 | 5 |
8/15/14 16:12 | 8/14/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | S.d | -390 | 29.98 | 5 | -13 | -100 | 0 | D | | | -32 | -5 | -10 | 7 | 1 | 0 | -1 | -12 | -14 | 13 | 27 | 5 |
7/16/14 18:25 | 7/14/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | M.d | 18 | 3.54 | 10 | 5 | | 0 | D | | | -41 | -26 | -9 | -18 | -18 | -10 | -8 | -4 | 6 | 7 | 46 | 17 |
7/16/14 18:25 | 7/14/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | SVP Gen. | S.d | -149 | 29.73 | 10 | -5 | -100 | 0 | D | | | -41 | -26 | -9 | -18 | -18 | -10 | -8 | -4 | 6 | 7 | 46 | 17 |
6/17/14 16:51 | 6/13/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | VP GC,Se | M.d | 33 | 3.65 | 11 | 9 | | 0 | D | | | 13 | -23 | -1 | 6 | 9 | 1 | 1 | 2 | -19 | -26 | 23 | -10 |
6/17/14 16:51 | 6/13/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | VP GC,Se | S.d | -305 | 33.94 | 11 | -9 | -100 | 0 | D | | | 13 | -23 | -1 | 6 | 9 | 1 | 1 | 2 | -19 | -26 | 23 | -10 |
5/21/14 18:51 | 5/19/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | VP GC,Se | M.d | 29 | 3.22 | 12 | 9 | | 0 | D | | | 61 | -28 | -12 | -8 | 0 | 1 | 6 | 5 | 15 | -3 | 12 | 12 |
5/21/14 18:51 | 5/19/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | VP GC,Se | S.d | -283 | 31.43 | 12 | -9 | -100 | 0 | D | | | 61 | -28 | -12 | -8 | 0 | 1 | 6 | 5 | 15 | -3 | 12 | 12 |
4/24/14 17:12 | 4/22/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | VP GC,Se | M.d | 2 | 0.9200 | 12 | 2 | | 0 | D | | | 49 | -41 | -31 | -13 | -9 | -13 | 2 | 7 | -2 | -12 | -8 | 7 |
4/24/14 17:12 | 4/22/14 | XLRN | Acceleron Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Quisel John D | MA | O | VP GC,Se | S.d | -72 | 35.85 | 12 | -2 | -100 | 0 | D | | | 49 | -41 | -31 | -13 | -9 | -13 | 2 | 7 | -2 | -12 | -8 | 7 |